David Feifel, a pioneering clinician in ketamine therapy, joins Dr. Sanjay Gupta, CNN’s Chief Medical Correspondent, to discuss the evolving landscape of ketamine treatment. They delve into the complexities of ketamine's dual identity as both a party drug and a potential mental health savior. The conversation highlights ethical concerns, risks of dependency, and the critical importance of a safe treatment environment. They also explore the need for informed consent and the role of psychotherapy in enhancing the treatment's effectiveness.

Master clinician and brain scientist, David Feifel, discusses brain hacking topics like ketamine therapy, transcranial magnetic stimulation, and neural enhancement. They explore the use of psychedelics in psychiatry, advancements in depression treatment, and the balancing of risks in medicine. The podcast delves into patient-centered care, therapeutic applications of ketamine, brain stimulation techniques, and the importance of social connections for personal achievements.